{"id":"https://openalex.org/W2506402287","doi":"https://doi.org/10.1182/blood.v126.23.3407.3407","title":"HemobloginA2 Levels Associate with Lower ESA-Dose in African-Americans with Sickle Cell Trait and End-Stage Kidney Disease","display_name":"HemobloginA2 Levels Associate with Lower ESA-Dose in African-Americans with Sickle Cell Trait and End-Stage Kidney Disease","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2506402287","doi":"https://doi.org/10.1182/blood.v126.23.3407.3407","mag":"2506402287"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.3407.3407","doi":"https://doi.org/10.1182/blood.v126.23.3407.3407","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.3407.3407","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075327487","display_name":"Vimal Kumar Derebail","orcid":"https://orcid.org/0000-0002-7662-7497","observed_orcids":["https://orcid.org/0000-0002-7662-7497"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Vimal K. Derebail","raw_affiliation_strings":["UNC Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046199747","display_name":"Kenneth I. Ataga","orcid":"https://orcid.org/0000-0002-4501-9982","observed_orcids":["https://orcid.org/0000-0002-4501-9982"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth I. Ataga","raw_affiliation_strings":["Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078458815","display_name":"Abhijit V. Kshirsagar","orcid":"https://orcid.org/0000-0001-6669-7523","observed_orcids":["https://orcid.org/0000-0001-6669-7523"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Abhijit V Kshirsagar","raw_affiliation_strings":["UNC Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112029282","display_name":"Micah J. Mooberry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Micah J. Mooberry","raw_affiliation_strings":["Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042064091","display_name":"Patrick H. Nachman","orcid":"https://orcid.org/0000-0002-5890-2862","observed_orcids":["https://orcid.org/0000-0002-5890-2862"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Patrick H Nachman","raw_affiliation_strings":["UNC Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013658598","display_name":"Nigel S. Key","orcid":"https://orcid.org/0000-0002-8930-4304","observed_orcids":["https://orcid.org/0000-0002-8930-4304"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nigel S. Key","raw_affiliation_strings":["Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5042064091","https://openalex.org/A5075327487","https://openalex.org/A5078458815"],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.26416259,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"126","issue":"23","first_page":"3407","last_page":"3407"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.5634999871253967,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.5634999871253967,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.43160000443458557,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sickle-cell-trait","display_name":"sickle cell trait","score":0.9490000009536743},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.8849999904632568},{"id":"https://openalex.org/keywords/hemodialysis","display_name":"hemodialysis","score":0.875},{"id":"https://openalex.org/keywords/erythropoiesis-stimulating-agents","display_name":"erythropoiesis-stimulating agents","score":0.949999988079071},{"id":"https://openalex.org/keywords/esa-dose","display_name":"ESA dose","score":0.7379999756813049},{"id":"https://openalex.org/keywords/hemoglobin-a2","display_name":"hemoglobin A2","score":0.9869999885559082},{"id":"https://openalex.org/keywords/hemoglobin-s","display_name":"hemoglobin S","score":0.8809999823570251},{"id":"https://openalex.org/keywords/fetal-hemoglobin","display_name":"fetal hemoglobin","score":0.8399999737739563},{"id":"https://openalex.org/keywords/african-americans","display_name":"African Americans","score":0.7570000290870667},{"id":"https://openalex.org/keywords/anemia-of-chronic-kidney-disease","display_name":"anemia of chronic kidney disease","score":0.7350000143051147},{"id":"https://openalex.org/keywords/iron-dosing","display_name":"iron addition","score":0.6050000190734863},{"id":"https://openalex.org/keywords/iron-saturation","display_name":"iron saturation","score":0.6359999775886536},{"id":"https://openalex.org/keywords/hemoglobin-variants","display_name":"hemoglobin variants","score":0.4729999899864197},{"id":"https://openalex.org/keywords/cation-exchange-hplc","display_name":"cation-exchange HPLC","score":0.7059999704360962},{"id":"https://openalex.org/keywords/parathyroid-hormone","display_name":"parathyroid hormone","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8046303987503052},{"id":"https://openalex.org/C153852466","wikidata":"https://www.wikidata.org/wiki/Q907072","display_name":"Transferrin saturation","level":4,"score":0.7242215871810913},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6031986474990845},{"id":"https://openalex.org/C2778063415","wikidata":"https://www.wikidata.org/wiki/Q391744","display_name":"Hemodialysis","level":2,"score":0.586333155632019},{"id":"https://openalex.org/C2778917026","wikidata":"https://www.wikidata.org/wiki/Q43041","display_name":"Hemoglobin","level":2,"score":0.5838977098464966},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.5492267608642578},{"id":"https://openalex.org/C2779978075","wikidata":"https://www.wikidata.org/wiki/Q202301","display_name":"Dialysis","level":2,"score":0.5245856642723083},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5053530335426331},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.4978044033050537},{"id":"https://openalex.org/C3019040382","wikidata":"https://www.wikidata.org/wiki/Q476921","display_name":"End stage renal disease","level":3,"score":0.486014187335968},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4483658969402313},{"id":"https://openalex.org/C54847362","wikidata":"https://www.wikidata.org/wiki/Q177635","display_name":"Nephrology","level":2,"score":0.42682409286499023},{"id":"https://openalex.org/C2777417653","wikidata":"https://www.wikidata.org/wiki/Q1313081","display_name":"Iron deficiency","level":3,"score":0.3674106001853943}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.3407.3407","doi":"https://doi.org/10.1182/blood.v126.23.3407.3407","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.3407.3407","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2156603812","https://openalex.org/W1986011035","https://openalex.org/W2102315160","https://openalex.org/W2568163958","https://openalex.org/W2792062201","https://openalex.org/W2057261911","https://openalex.org/W2058630362","https://openalex.org/W2741354046","https://openalex.org/W2279562857","https://openalex.org/W2804689353"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"We":[2,75,182,194,211],"have":[3,24],"previously":[4],"demonstrated":[5,363],"that":[6,334,438],"African-Americans":[7,101],"with":[8,87,205,308,331,369,393,416,468],"end-stage":[9],"kidney":[10],"disease":[11],"on":[12,83,102,107,152,350],"hemodialysis":[13,84,391,466],"receive":[14,395],"higher":[15,64,396,411],"doses":[16,186,190,397],"of":[17,35,43,56,92,99,110,145,198,201,241,270,304,376,398,427,571],"erythropoietin-stimulating":[18],"agents":[19],"(ESA)":[20],"if":[21,77],"they":[22],"also":[23,212],"sickle":[25,30,469],"cell":[26,31,470],"trait":[27,255,260],"(SCT).":[28],"In":[29,300],"disease,":[32],"the":[33,41,90,108,199,242,248,262,271],"severity":[34],"clinical":[36,291,461],"manifestations":[37],"is":[38,85],"modified":[39],"by":[40,50,118,385],"quantity":[42],"hemoglobin":[44,51,57,111,203,253,266,403],"S":[45],"(HbS)":[46],"expressed":[47],"and":[48,131,154,162,178,187,231,256,261,280,292,358,448,460,563],"attenuated":[49],"F":[52],"(HbF)":[53],"expression.":[54],"Measures":[55],"A2":[58],"(HbA2)":[59],"are":[60,295,414,451],"reported":[61],"to":[62,72,221,400,453,573],"be":[63,70,430],"in":[65,80,89,297,379,433,445,463],"SCT":[66,81,126,394],"although":[67],"this":[68,446,455],"may":[69,429,441],"related":[71],"testing":[73],"artifact.":[74],"evaluated":[76],"ESA":[78,185,206,310,332,370,381,399,418,443],"dosing":[79,230],"patients":[82,244,392,467],"associated":[86,415],"differences":[88],"amount":[91,200],"these":[93,409,435],"hemoglobins.":[94],"Methods:":[95],"From":[96],"a":[97,165,226,237,326,364],"cohort":[98],"155":[100,243],"hemodialysis,":[103],"we":[104],"collected":[105],"data":[106,294,462],"level":[109],"type":[112,204],"(HbA,":[113],"HbS,":[114],"HbA2,":[115,380],"HbF)":[116],"determined":[117],"cation-exchange":[119],"high-pressure":[120],"liquid":[121],"chromatography":[122],"(HPLC)":[123],"studies.":[124],"Only":[125],"individuals":[127,249],"were":[128,134,160,235,282],"included.":[129],"Demographics":[130],"medical":[132],"history":[133,144],"reviewed":[135,161],"for":[136,168,347,423],"covariates":[137],"including":[138],"age,":[139,348],"sex,":[140],"BMI,":[141],"diabetes":[142],"mellitus,":[143],"gastrointestinal":[146],"bleeding,":[147],"vascular":[148],"access":[149],"type,":[150],"time":[151,349],"dialysis":[153],"missed":[155],"treatments.":[156],"All":[157],"laboratory":[158],"studies":[159,180,450],"averaged":[163],"from":[164,225],"3-month":[166],"period":[167],"ferritin,":[169],"iron":[170,189,232,352,354],"saturation,":[171,356],"parathyroid":[172,359],"hormone,":[173,360],"serum":[174,176],"albumin,":[175],"phosphorus,":[177],"adequacy":[179,548],"(Kt/V).":[181],"calculated":[183],"delivered":[184],"intravenous":[188],"as":[191,405,555,561],"per-treatment":[192],"dosing.":[193],"compared":[195],"continuous":[196],"measures":[197,426],"each":[202,374],"dose":[207,311,333,371,382,419],"using":[208,218],"Spearman\u00d5s":[209],"correlation.":[210],"constructed":[213],"multivariable":[214],"linear":[215],"regression":[216],"models":[217],"backward":[219],"elimination":[220],"identify":[222],"relevant":[223,290,569],"confounders":[224],"full":[227],"model.":[228],"Iron":[229,526],"percent":[233,303,355,377],"saturation":[234,527],"retained":[236],"priori.":[238],"Results:":[239],"24(15%)":[240],"had":[245,252,258,264,286,325],"SCT.":[246],"Of":[247],"excluded,":[250],"9":[251],"C":[254],"1":[257],"\u03b2-thalassemia":[259],"rest":[263],"normal":[265],"variants.":[267],"Median":[268,562],"age":[269],"24":[272,464],"subjects":[273],"was":[274,313,335,383],"62.1":[275,474],"years":[276],"(IQR":[277],"48.7,":[278],"69.2)":[279,476],"13":[281,481],"male":[283],"(54.2%).":[284],"None":[285],"measurable":[287],"HbF.":[288],"Other":[289],"demographic":[293],"presented":[296,554,560],"Table":[298,457],"1.":[299,458],"unadjusted":[301],"analyses,":[302],"HbS":[305,511],"weakly":[306],"correlated":[307],"average":[309],"but":[312],"not":[314],"statistically":[315,336,365],"significant":[316,337,366],"(\u03c1=":[317,338],"-0.27,":[318],"95%":[319,340],"-0.61,":[320],"0.15;":[321],"p=0.2).":[322],"HbA2":[323,361,412,428,439,516],"however":[324],"relatively":[327],"strong":[328],"negative":[329,367],"correlation":[330,368],"-0.44,":[339],"CI":[341],"-0.72,":[342],"-0.05;":[343],"p=0.03).":[344],"After":[345],"adjusting":[346],"dialysis,":[351],"dose,":[353],"albumin":[357],"still":[362],"(p=0.04).":[372],"For":[373],"tenth":[375],"increase":[378],"lower":[384,417],"approximately":[386],"440":[387],"U.":[388],"Conclusions:":[389],"African-American":[390,465],"achieve":[401],"similar":[402],"levels":[404,413],"other":[406],"patients.":[407],"Among":[408],"individuals,":[410],"even":[420],"after":[421],"adjustment":[422],"confounders.":[424],"Although":[425],"less":[431],"accurate":[432],"SCT,":[434],"results":[436],"suggest":[437],"content":[440],"attenuate":[442],"resistance":[444],"population,":[447],"further":[449],"needed":[452],"understand":[454],"relationship.":[456],"Demographic":[459],"trait.":[471],"Age":[472],"(yrs)":[473,492],"(48.7,":[475],"Male":[477],"sex":[478],"(N,":[479,497],"%)":[480,498],"(54.2)":[482],"Body":[483],"mass":[484],"index":[485],"(kg/m2)":[486],"26.1":[487],"(23.1,":[488],"30.7)":[489],"Dialysis":[490,547],"vintage":[491],"6.2":[493],"(2.9,":[494],"9.3)":[495],"Diabetes":[496],"16":[499],"(66.7)":[500],"Arteriovenous":[501],"fistula":[502],"(N,%)":[503],"14":[504],"(58.3)":[505],"Hemoglobin":[506],"(gm/dl)":[507],"11.9":[508],"(11.4,":[509],"12.5)":[510],"(%)":[512,517],"35.8":[513],"(31.4,":[514],"38.4)":[515],"4.1":[518],"(3.9,":[519,540],"4.4)":[520],"Ferritin":[521],"(ng/ml)":[522],"831.3":[523],"(610.7,":[524],"1121.0)":[525],"%":[528],"29":[529],"(24.7,":[530],"37.2)":[531],"iPTH":[532],"(pg/ml)":[533],"451.6":[534],"(269.3,":[535],"715.2)":[536],"Albumin":[537],"(mg/dl)":[538],"4.0":[539],"4.1)":[541],"Phosphorus":[542],"(mg/ml)":[543],"5.7":[544],"(4.6,":[545],"6.3)":[546],"(Kt/V)":[549],"1.47":[550],"(1.35,":[551],"1.54)":[552],"Counts":[553],"N":[556],"(%).":[557],"Continuous":[558],"variables":[559],"Interquartile":[564],"Range":[565],"(IQR)":[566],"Disclosures":[567],"No":[568],"conflicts":[570],"interest":[572],"declare.":[574]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-08-23T00:00:00"}